SCHEMBL7496806

SCHEMBL7496806

Clc1ccccc1[CH]N1CCNCC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 4/20 0.53
RXFP1 Q9HBX9 1/20 0.45
DRD2 P14416 1/20 0.44
DRD3 P35462 1/20 0.44
DYRK2 Q92630 1/20 0.43
ALDH1A1 P00352 1/20 0.42
SIGMAR1 Q99720 2/20 0.40
PIM1 P11309 1/20 0.40
PIM3 Q86V86 1/20 0.40
PIM2 Q9P1W9 1/20 0.40
SLC6A2 P23975 3/20 0.40
SLC6A4 P31645 3/20 0.40
SLC6A3 Q01959 3/20 0.40
HTR3A P46098 2/20 0.39
HTR3E A5X5Y0 1/20 0.39
HTR3B O95264 1/20 0.39
HTR3D Q70Z44 1/20 0.39
HTR3C Q8WXA8 1/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2D6 P10635 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27765777 0.80 MAPT (0.47) DYRK2ALDH1A1CYP2C9CYP2C19CYP3A4
SCHEMBL20531052 0.77 IKBKB (0.43) ADRB1DYRK2ALDH1A1SIGMAR1SLC6A2
SCHEMBL20531049 0.77 NFE2L2 (0.45) ADRB1DYRK2SIGMAR1SLC6A2SLC6A4
SCHEMBL1852772 0.77 MAPT (0.46) DRD2DRD3ALDH1A1CYP2D6MAPT
SCHEMBL20531065 0.77 ADRB1 (0.52) ADRB1ALDH1A1SIGMAR1SLC6A2SLC6A4
SCHEMBL7503359 0.72 ADRB1 (0.53) ADRB1RXFP1ALDH1A1SIGMAR1SLC6A2
SCHEMBL949805 0.71 SIGMAR1 (0.50) ADRB1ALDH1A1SIGMAR1SLC6A2SLC6A4
SCHEMBL9564606 0.71 ADRB1 (0.42) ADRB1RXFP1SLC6A2SLC6A4SLC6A3
SCHEMBL29446047 0.69 ADRB1 (1.00) ADRB1DRD2DRD3ALDH1A1SIGMAR1
1,2-Dichlorobenzene SCHEMBL27980811 0.69 ADRB1 (0.59) ADRB1RXFP1DRD2DRD3SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3386979-A1 2-PHENYL-3-(PIPERAZINOMETHYL)IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AS BLOCKERS OF TASK-1 AND TASK-2 CHANNELS, FOR THE TREATMENT OF SLEEP-RELATED BREATHING DISORDERS Bayer Pharma Aktiengesellschaft (DE) 2018-10-17 EP disclosed
EP-1222167-A2 METHOD FOR PRODUCING INDOLE DERIVATIVES ON A SOLID PHASE MERCK PATENT GmbH (DE) 2002-07-17 EP disclosed
WO-2001023353-A2 METHOD FOR PRODUCING INDOLE DERIVATIVES ON A SOLID PHASE MERCK PATENT GMBH (DE) 2001-04-05 WO disclosed